Literature DB >> 10586124

Physiopathology of urticaria.

M Doutre.   

Abstract

Urticaria is a common disorder that affects as many of 20% of all people at sometime during their lives. It is a cutaneous reaction pattern for which there are multiple potential causes. Its physiopathology is poorly defined. The vascular changes observed in urticarial lesions can be attributed to the release of mediators: histamine plays an essential role but others mediators, such as serotonin, eicosanoids, kinins, neuropeptides. may also be involved. These mediators are synthetized by mast cells which are the major effector cell type. However, other cells, basophils, mononuclear cells, platelets, endothelial cells have also been implicated. During immediate hypersensitivity reaction, mast cells and basophils are activated by allergens through cross linking of cell-surface-bound IgE. However, more often than not, these cells are stimulated by non-immunological mechanisms. At present, some data are better understood: in urticaria, there is a late phase reaction which involves cytokines and cell adhesion molecules. Recent work has also demonstrated the role of circulating functional histamine - releasing auto antibodies that bind to the high affinity IgE receptor (FcepsilonRI) or, less commonly, to IgE. As the pathophysiological mechanisms responsible for urticaria are better defined, therapeutic agents other than H1 histamines, should be available.

Entities:  

Mesh:

Year:  1999        PMID: 10586124

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

Review 1.  Eosinophils and urticaria.

Authors:  Delphine Staumont-Sallé; David Dombrowicz; Monique Capron; Emmanuel Delaporte
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

2.  Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.

Authors:  Stephan Seeliger; Jörg Buddenkotte; Anjona Schmidt-Choudhury; Carine Rosignoli; Victoria Shpacovitch; Ulrike von Arnim; Dieter Metze; Roman Rukwied; Martin Schmelz; Ralf Paus; Johannes J Voegel; Wolfgang E Schmidt; Martin Steinhoff
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 3.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 4.  Pathophysiology of urticaria.

Authors:  Ana Hennino; Fréderic Bérard; Isabelle Guillot; Nathalie Saad; Auore Rozières; Jean-François Nicolas
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

Review 5.  Late-phase urticaria Update.

Authors:  Naotomo Kambe; Aki Kitao; Chikako Nishigori; Yoshiki Miyachi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.